321 related articles for article (PubMed ID: 10765854)
1. The effect of parotid salivary flow rate on the levels of salivary antimicrobial proteins in patients with Sjögren's syndrome.
Zipp MM; Yasbin L; al-Hashimi I
Quintessence Int; 1999 Oct; 30(10):700-5. PubMed ID: 10765854
[TBL] [Abstract][Full Text] [Related]
2. Minor gland saliva flow rate and proteins in subjects with hyposalivation due to Sjogren's syndrome and radiation therapy.
Eliasson L; Almståhl A; Lingström P; Wikström M; Carlén A
Arch Oral Biol; 2005 Mar; 50(3):293-9. PubMed ID: 15740707
[TBL] [Abstract][Full Text] [Related]
3. Effect of xerostomic medications on stimulated salivary flow rate in patients with Sjögren's syndrome.
Simmons DD; Al-Hashimi I; Haghighat N
Quintessence Int; 2000 Mar; 31(3):196-200. PubMed ID: 11203926
[TBL] [Abstract][Full Text] [Related]
4. Comparison of salivary calmodulin binding proteins in Sjögren's syndrome and healthy individuals.
Deming FP; Al-Hashimi I; Haghighat N; Hallmon WW; Kerns DG; Abraham C; Rivera-Hidalgo F
J Oral Pathol Med; 2007 Mar; 36(3):132-5. PubMed ID: 17305633
[TBL] [Abstract][Full Text] [Related]
5. Salivary anti-spectrin autoantibodies in Sjögren's syndrome.
Moody M; Zipp M; Al-Hashimi I
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Mar; 91(3):322-7. PubMed ID: 11250630
[TBL] [Abstract][Full Text] [Related]
6. Salivary factors in children with recurrent parotitis. Part 2: Protein, albumin, amylase, IgA, lactoferrin lysozyme and kallikrein concentrations.
Ericson S; Sjöbäck I
Swed Dent J; 1996; 20(5):199-207. PubMed ID: 9000329
[TBL] [Abstract][Full Text] [Related]
7. [Sialochemical studies in Sjögren disease].
Menstell S; Maier H; Adler D; Deeg M
Laryngorhinootologie; 1990 Jun; 69(6):320-1. PubMed ID: 1696100
[TBL] [Abstract][Full Text] [Related]
8. Protein and mucin retention on oral mucosal surfaces in dry mouth patients.
Pramanik R; Osailan SM; Challacombe SJ; Urquhart D; Proctor GB
Eur J Oral Sci; 2010 Jun; 118(3):245-53. PubMed ID: 20572857
[TBL] [Abstract][Full Text] [Related]
9. Standardization of a simple method to study whole saliva: clinical use in different pathologies.
Tumilasci OR; Cardoso EM; Contreras LN; Belforte J; Arregger AL; Ostuni MA
Acta Odontol Latinoam; 2006; 19(2):47-51. PubMed ID: 17645210
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the concentration and output of whole salivary constituents in patients with Sjögren's syndrome.
van der Reijden WA; van der Kwaak JS; Veerman EC; Nieuw Amerongen AV
Eur J Oral Sci; 1996 Aug; 104(4 ( Pt 1)):335-40. PubMed ID: 8930579
[TBL] [Abstract][Full Text] [Related]
11. A comparison of salivary gland hypofunction in primary and secondary Sjögren's syndrome.
Dawson LJ; Holt DJ; Higham SM; Longman LP; Field EA
Oral Dis; 2001 Jan; 7(1):28-30. PubMed ID: 11354918
[TBL] [Abstract][Full Text] [Related]
12. Sarcoidosis and Sjögren's syndrome: clinical and salivary evaluation.
Mansour MJ; He C; Al-Farra ST; Khuder SA; Wright JM; Kessler HP; Hinton RJ; Al-Hashimi I
J Oral Pathol Med; 2013 Sep; 42(8):594-9. PubMed ID: 23480241
[TBL] [Abstract][Full Text] [Related]
13. Salivary: flow and proteins of the innate and adaptive immunity in the limited and diffused systemic sclerosis.
Knaś M; Zalewska A; Waszkiewicz N; Szulimowska J; Dziezcioł J; Sierakowski S; Waszkiel D
J Oral Pathol Med; 2014 Aug; 43(7):521-9. PubMed ID: 25184163
[TBL] [Abstract][Full Text] [Related]
14. Proteomic study of salivary peptides and proteins in patients with Sjögren's syndrome before and after pilocarpine treatment.
Peluso G; De Santis M; Inzitari R; Fanali C; Cabras T; Messana I; Castagnola M; Ferraccioli GF
Arthritis Rheum; 2007 Jul; 56(7):2216-22. PubMed ID: 17599740
[TBL] [Abstract][Full Text] [Related]
15. Assessment of SS-A and SS-B in parotid saliva of patients with Sjögren's syndrome.
Hammi AR; Al-Hashimi IH; Nunn ME; Zipp M
J Oral Pathol Med; 2005 Apr; 34(4):198-203. PubMed ID: 15752253
[TBL] [Abstract][Full Text] [Related]
16. Major salivary gland function in primary Sjögren's syndrome and its relationship to clinical features.
Atkinson JC; Travis WD; Pillemer SR; Bermudez D; Wolff A; Fox PC
J Rheumatol; 1990 Mar; 17(3):318-22. PubMed ID: 2332852
[TBL] [Abstract][Full Text] [Related]
17. Clinical Dental Research Center an education & research project: total salivary protein concentration in patients with Sjögren's syndrome and a healthy control group.
Jones V; Streckfus CF
Miss Dent Assoc J; 1998; 54(2):40-1. PubMed ID: 9800564
[No Abstract] [Full Text] [Related]
18. Salivary secretory leukocyte protease inhibitor increases in HIV infection.
Lin AL; Johnson DA; Stephan KT; Yeh CK
J Oral Pathol Med; 2004 Aug; 33(7):410-6. PubMed ID: 15250833
[TBL] [Abstract][Full Text] [Related]
19. Low salivary dehydroepiandrosterone and androgen-regulated cysteine-rich secretory protein 3 levels in Sjögren's syndrome.
Laine M; Porola P; Udby L; Kjeldsen L; Cowland JB; Borregaard N; Hietanen J; Ståhle M; Pihakari A; Konttinen YT
Arthritis Rheum; 2007 Aug; 56(8):2575-84. PubMed ID: 17665393
[TBL] [Abstract][Full Text] [Related]
20. Variability of flow rate when collecting stimulated human parotid saliva.
Burlage FR; Pijpe J; Coppes RP; Hemels ME; Meertens H; Canrinus A; Vissink A
Eur J Oral Sci; 2005 Oct; 113(5):386-90. PubMed ID: 16202025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
